Latest Rheumatology News
Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis
posted January 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
PCP-Specialist Cotraining Improves Patient Experiences
posted January 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Women With Employer Insurance More Likely to Report Unaffordability of Care
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Nurse-Driven Protocol Ups Pneumococcal Vaccination Rates
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Trends Reported in Vaccination Coverage for Adolescents for 2025 Related Articles
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Rheumatology Conference Highlights
Rheumatology Monthly Briefings
Rheumatology Conference News
Stay Connected
